about
Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancerMechanisms of Progranulin Action and Regulation in Genitourinary CancersCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaA novel role for drebrin in regulating progranulin bioactivity in bladder cancerProline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.In vitro functional effects of XPC gene rare variants from bladder cancer patients.microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.Overexpression of KLF13 and FGFR3 in oral cancer cells.Deregulation of Rab and Rab effector genes in bladder cancer.A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionSide population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancerExpression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.Molecular biology of bladder cancer.Modelling bladder cancer in mice: opportunities and challenges.Characteristic patterns of microRNA expression in human bladder cancerQuantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.Novel strategies for treating relapsed/refractory urothelial carcinoma.A systematic experimental evaluation of microRNA markers of human bladder cancer.SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.Contemporary management of low-risk bladder cancer.Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.Mechanisms of recurrence of Ta/T1 bladder cancer.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability.A new tumor suppressor role for the Notch pathway in bladder cancer.SLC14A1: a novel target for human urothelial cancer.Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways.K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in miceIdentification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
P2860
Q22001096-28F6AB57-4465-4C94-A84D-3F44795813FFQ26741917-857D68FA-EDE3-434E-8CF1-64DB7EF4D8CFQ26860953-7376B3ED-5F6D-43DC-BE8B-880B19A6F1F1Q28115186-C1FBEA44-59A6-4A9E-941D-B2EFF5002BA2Q31078386-34347B3E-A965-48E2-A764-9870E6FBD2B1Q33710142-56ECE98C-6C5F-4A42-8EFD-E54196736A1CQ33805826-508F657F-4000-45BF-99F3-C533715143C9Q33853224-230C6733-7507-49D5-9DD5-3D03AB64EF59Q33882569-8F365C49-4B7F-44C4-AFC0-5DEE32ED1497Q33928136-B912FCA1-57E0-497E-93DD-2E3B6A702EDEQ34314461-A98B1FB6-3B15-48F7-BB80-418BBBF9CAAAQ34462001-D5DC1CB2-55E3-422F-8164-FB2AFDEA4009Q34505763-ECD621C7-DA47-468F-B2CD-8C933EDC67C7Q34544501-AB687317-323C-473F-9F0B-9B38D68160EFQ34962445-495FD869-4FEF-45D9-A451-06A7BB58C886Q35034773-7093257E-628E-4A6C-B5A1-DDC318B7A78CQ35266398-F6650915-1D6D-45B0-9A77-12F0DBE9D481Q35266400-6AB7A1B5-DD8C-486D-80E8-4DAF72A8EE4CQ35285703-F4F7B339-D310-4E33-9E6D-CAF43AEA58EEQ36516905-BF02B53D-30F0-4B75-9C39-2F0070CF7570Q36862682-0B6E51E7-2645-43B0-9BAC-EB7C2173F705Q36995686-909F2DAE-EC03-410C-8D2C-8FF21B22F184Q37309960-1B563193-92B1-4D85-91DC-CE746FABA14DQ37329523-4EFF181F-B694-48B4-B72B-BEB58125A921Q37457751-7D98CF3B-EDB6-4A82-9424-2918172FEAD1Q37480033-88DBCEF6-6055-4455-840C-F0F00A03855FQ37828064-A48D625C-2FD7-4D56-989E-FD3AA99A9249Q38068225-6A39D00B-7803-47C8-87E8-B432F8C0080AQ38589612-3E744ABF-34B4-4B0B-B6D9-2073C4240167Q38667456-D46CAF53-0783-489A-9C2E-5C81C29799CEQ38930235-AD9C0EC5-E4C0-4B71-A95A-FB2B9DF2559FQ38959215-B6DE5025-1060-4FD4-A096-34D8BD178598Q39356231-6658B42D-613A-4C9D-A7DF-751DB9ADF3FFQ39493826-5D534EE7-A697-4BD0-B435-642F978081BFQ39985659-B6E50EF2-EB89-4677-96C1-EE7EB4CCC05CQ41788062-515EBFCB-AF16-44BB-8463-C592FCC4EAA1Q42214617-C5445A7C-9879-40B9-886E-58006B25FCBCQ42290198-48A8D7FE-A022-45A3-8B67-B03FF3B8BBD7Q44423282-B2579C16-369A-4166-96BD-E0BC12EA070BQ47386898-C3C287C8-FCED-40AB-BEA6-D650BF626FF2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular pathogenesis of bladder cancer.
@en
Molecular pathogenesis of bladder cancer.
@en-gb
Molecular pathogenesis of bladder cancer.
@nl
type
label
Molecular pathogenesis of bladder cancer.
@en
Molecular pathogenesis of bladder cancer.
@en-gb
Molecular pathogenesis of bladder cancer.
@nl
prefLabel
Molecular pathogenesis of bladder cancer.
@en
Molecular pathogenesis of bladder cancer.
@en-gb
Molecular pathogenesis of bladder cancer.
@nl
P2860
P1476
Molecular pathogenesis of bladder cancer.
@en
P2860
P2888
P304
P356
10.1007/S10147-008-0812-0
P577
2008-08-15T00:00:00Z